The main objective of the study is to challenge current statements regarding systematic screening of asymptomatic HHT patients for neurovascular manifestations. We are thus seeking to answer a question many screening programs have faced. A screening program should screen for a manageable problem, by a method that is cost effective and safe. Finally, the positive effect of screening program should outweigh the negative and not cause unnecessary concerns or harm for the patients.
|Effektiv start/slut dato||01/11/2022 → 31/03/2025|